Abstract |
Small fiber neuropathy (SFN) selectively affects small diameter sensory and/or autonomic axons. Pain and autonomic dysfunctions are the most common symptoms. SFN occurs in several autoimmune diseases and autoantibodies against neuronal proteins may play a role in SFN pathophysiology. Anti-GQ1b antibody has been associated with Miller Fisher syndrome, Bickerstaff's brainstem encephalitis, acute ophthalmoplegia, pharyngeal-cervical-brachial weakness and peripheral neuropathy involving large fibers. Isolated SFN associated with anti-GQ1b antibodies has not been previously reported. Here we report a 45-year-old woman presenting with highly positive anti-GQ1b titer and selective SFN without central nervous system or peripheral large nerve involvement. She improved upon administration of adalizumab. Further studies will clarify a possible pathogenetic role of antiganglioside antibodies in SFN. Moreover, the recognition of antiganglioside antibodies in SFN may have therapeutic consequences with patients who would benefit from immunotherapy.
|
Authors | Valentina Favoni, Rocco Liguori, Alex Incensi, Enrico Fileccia, Vincenzo Donadio |
Journal | Journal of the neurological sciences
(J Neurol Sci)
Vol. 388
Pg. 192-194
(05 15 2018)
ISSN: 1878-5883 [Electronic] Netherlands |
PMID | 29627021
(Publication Type: Case Reports, Letter)
|
Copyright | Copyright © 2018 Elsevier B.V. All rights reserved. |
Chemical References |
- Autoantibodies
- Biomarkers
- Gangliosides
- Immunoglobulin M
- GQ1b ganglioside
|
Topics |
- Autoantibodies
(metabolism)
- Biomarkers
(metabolism)
- Female
- Gangliosides
(immunology)
- Humans
- Immunoglobulin M
(metabolism)
- Incidental Findings
- Middle Aged
- Small Fiber Neuropathy
(diagnosis, drug therapy, immunology, pathology)
|